‘Brainless’ US MFN Policy Could Drive Pharma Investment To Europe

 
• By Francesca Bruce
  
Plans for a most favored nations drug pricing policy are creating an unpredictable environment, which may drive investment to Europe. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access